Parker, E. M. | Search bioRxiv

bioRxiv2022

CACNB4 overexpression decreases dendritic spine density in sex-specific manner

The canonical voltage-gated calcium channel (VGCC) subunit complex is comprised of the 1 subunit, the ion permeable channel, plus three auxiliary subunits: {beta}, 2{delta} and {gamma}. {beta} is the most extensively studied auxiliary subunit and is necessary for proper forward trafficking of the 1 subunit to the plasma membrane. 1 subunits mediate voltagedependent movement of calcium ions into the cytoplasm of neurons, including at dendritic sites, where increased intracellular calcium initiates signaling cascades that shape structural and functional plasticity of dendritic spines. Genetic studies strongly implicate calcium signaling dysfunction in the etiology of neurodevelopmental disorders including schizophrenia. Dendritic spine density (DSD) is significantly decreased in schizophrenia in primary auditory cortex where DSD is driven by loss of small spines, and small spine loss is associated with increased peptide levels of ALFDFLK found in the VGCC {beta} subunit {beta}4. Overexpessing CACNB4 to increase {beta}4 levels selectively reduced small spine density in cortical neuron cultures. The studies described herein set out to validate this in vitro observation in an intact mammalian system within a neurodevelopmental context. We overexpressed CACNB4 in neurodevelopment and assessed DSD and morphology in cerebral cortex of male and female mice at an adult timpoint. We then characterized {beta} protein levels and {beta}4 protein-protein interactions in male and female mouse cortex. Overexpression selectively reduced small dendritic spine density but this effect was present only in female mice and did not appear to result from estrous stage. Instead, the sex-dependent effect on DSD corresponded to sex differences in the {beta}4 interactome of male versus female mice: the VGCC {beta} subunit {beta}1b was significantly enriched in the {beta}4 interactome of brain tissue of male mice, and thus may have served to mitigate VGCC overexpression-mediated spine loss in male mice.

neuroscience↗

bioRxiv2021

BACE1, but not BACE2, function is critical for metabolic disorders induced by high-fat diets in C57BL/6N mice

Aims/hypothesisBeta-site amyloid precursor protein-cleaving enzyme 1 (BACE1) is required for the production of toxic amyloid peptides and is highly expressed in the brain, but also to a lesser extent in major peripheral organs such as muscle and liver. In contrast, BACE2 is mainly expressed in peripheral tissues and is enriched in pancreatic beta cells, where it regulates beta- cell function and mass. Previous reports demonstrated that loss of BACE1 function decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice, whereas mice lacking Bace2 exhibit reduced blood glucose levels, improved intraperitoneal glucose tolerance and increased beta-cell mass. Impaired glucose homeostasis and insulin resistance are hallmarks of type 2 diabetes and have been implicated in Alzheimers disease. Therefore, we tested the contribution of the individual BACE isoforms to those metabolic phenotypes by placing Bace1 knockout (KO), Bace2 KO, Bace1/2 double knockout (dKO) and wild-type (WT) mice on a high-fat high-cholesterol diet (HFD) for 16 weeks. MethodsBace1 KO (n = 18), Bace2 KO (n = 18), Bace1/2 dKO (n = 18) and WT C57BL/6N mice (n = 54) were fed a HFD for 16 weeks (age 9-25 weeks). Body composition was measured before initiation of the HFD and after 11 weeks of HFD. Oral glucose tolerance and insulin sensitivity tests were performed after 12 and 13 weeks of HFD, respectively, and full blood chemistry was analyzed after 16 weeks of HFD. The effects of subchronic BACE1/2 inhibition were assessed by administration of 10 mg/kg/day of the dual BACE1/2 inhibitor MBi-3 in a HFD fed to C57BL/6N mice for 3 weeks. ResultsBace1 KO and Bace1/2 dKO mice showed decreased body weight and improved glucose tolerance and insulin resistance vs. WT mice. Conversely, Bace2 KO mice did not show any significant differences in body weight, glucose tolerance or insulin resistance under our experimental conditions. Finally, subchronic MBi-3-mediated BACE1/2 inhibition in mice in conjunction with a HFD resulted in a modest improvement of glucose tolerance. Conclusions/interpretationOur data indicate that lack of BACE1 - but not BACE2 - function contributes mainly to the metabolic phenotypic changes observed in Bace1/2 dKO mice, suggesting that inhibition of BACE1 has the greater role (vs. BACE2) in any potential improvements in metabolic homeostasis. HIGHLIGHTSO_LIInsulin resistance may develop in the brains of patients with Alzheimers disease (83/85 characters) C_LIO_LIBACE1 and BACE2 may play a role in glucose homeostasis and insulin sensitivity (80/85 characters) C_LIO_LIBody weight in mice decreased with Bace1 KO and Bace1/2 KO but not Bace2 KO alone (83/85 characters) C_LIO_LIBace1 and Bace1/2, but not Bace2, KO improved glucose tolerance/insulin resistance (84/85 characters) C_LIO_LIImproved metabolic homeostasis may follow loss of BACE1 rather than BACE 2 activity (85/85 characters) C_LI

physiology↗